Business

The new firm will offer partners an expanded range of methods and workflows for small-molecule and peptide drug discovery.

AI can be used as a tool to provide patients and their families with more information, faster access and more affordable care, says Laura Cooley, editor in chief of the Journal of Patient Experience.

The company will use the funds to augment key content partnerships.

Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.

Managing AI agents and prompt engineering is not like standard software engineering, and no one has really figured out how to do it at scale reliably yet, says Dr. Lukasz Kowalczyk, a gastroenterologist and CEO of Soothien HealthTech Advisory.

The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.

Proceeds will go to settling debts and focusing on its business in the United States.

Agentic AI offers the potential to streamline clinical workflows, but healthcare organizations must carefully assess its risks to ensure safe and effective implementation.